Barbara Gayle Duncan Insider Trading $ADAP Adaptimmune Therapeutics PLC
Get free email notifications about insider trading for Barbara Gayle Duncan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barbara Gayle Duncan. Barbara Gayle Duncan is Director in IMMUNOMEDICS INC ($IMMU) and Director in Innoviva, Inc. ($THRX) and CEO in Euthymics Bioscience Inc ($DOVP) and Director in Euthymics Bioscience Inc ($DOVP) and President and CFO in Euthymics Bioscience Inc ($DOVP) and Director in MEDGENICS, INC. ($MDGN) and Chief Accounting Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Atea Pharmaceuticals, Inc. ($AVIR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in Ovid Therapeutics Inc. ($OVID) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Fusion Pharmaceuticals Inc. ($FUSN).
Barbara Gayle Duncan in Adaptimmune Therapeutics PLC
Trading Symbol: ADAPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Barbara Gayle Duncan: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 01 2020
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Barbara Gayle Duncan in Adaptimmune Therapeutics PLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, GNMX, AVIR, DOVP, FUSN, IMMU, THRX, ICPT, JNCE, OVID
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2020 | ADAP | Adaptimmune Therap ... | Duncan Barbara Gayle | Director | Option Exercise | A | 1.67 | 144,000 | 240,480 | 144,000 | |
Jul 03 2019 | ADAP | Adaptimmune Therap ... | Duncan Barbara Gayle | Director | Option Exercise | A | 0.61 | 124,000 | 75,640 | 124,000 | |
Jun 26 2018 | ADAP | Adaptimmune Therap ... | Duncan Barbara Gayle | Director | Option Exercise | A | 2.18 | 158,233 | 344,948 | 158,233 | |
Jul 03 2017 | ADAP | Adaptimmune Therap ... | Duncan Barbara Gayle | Director | Option Exercise | A | 0.75 | 228,765 | 171,574 | 228,765 |
Page: 1